Published in Journal of Crohns & Colitis • Jan 1, 2013
Authors:
Salvatore Vassallo
,
Grazia Caterina Messineo
Abstract
The clinical efficacy of a combination of adalimumab and azathioprine at WWeek 26 did not differ from that of adalimumab monotherapy in patients with Crohn's disease naïve to both medications.
